| CRMSX | FTHFX | CRMSX / FTHFX | |
| Total Expense Ratio | 1.31 | 0.64 | 205% |
| Annual Report Gross Expense Ratio | 1.31 | 0.64 | 205% |
| Fund Existence | 31 years | 15 years | - |
| Gain YTD | 19.797 | 17.111 | 116% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 73.2M | 12.1B | 1% |
| Annual Yield % from dividends | 0.83 | 0.56 | 148% |
| Returns for 1 year | 19.94 | 27.29 | 73% |
| Returns for 3 years | 19.85 | 54.50 | 36% |
| Returns for 5 years | -6.12 | 65.47 | -9% |
| Returns for 10 years | -0.38 | 244.71 | -0% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FFANX | 14.84 | 0.01 | +0.07% |
| Fidelity Asset Manager 40% | |||
| EPSPX | 29.64 | -0.04 | -0.13% |
| NYLI Epoch Global Equity Yield Class A | |||
| MSOIX | 38.48 | -0.14 | -0.36% |
| NYLI WMC Enduring Capital Class I | |||
| GAGCX | 38.69 | -0.17 | -0.44% |
| Gabelli Global Rising Income and Div AAA | |||
| MRSRX | 28.14 | -0.17 | -0.60% |
| MFS Research International R2 | |||